Live from the NIH registry
Studies recruiting near Mobile right now
Top 25 of 176 recruiting studies, sorted by proximity — each links to its official registry page
Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
Pain
N/A
Interventional 120 participants sought
Alabama Orthopedic Sports Medicine & Baldwin County Surgery Center — Daphne, Alabama (13.7 mi)
· Sponsor: Synaptrix, Inc.
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
The Center for Clinical Trials — Saraland, Alabama (10.2 mi)
· Sponsor: Ardelyx
A Study of Depemokimab in Participants of 6 to 11 Years of Age
Asthma
Phase 3
Interventional 34 participants sought
GSK Investigational Site — Mobile, Alabama (4.5 mi)
· Sponsor: GlaxoSmithKline
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Fairhope, AL Investigative Site 10004 — Fairhope, Alabama (16.6 mi)
· Sponsor: Colorado Prevention Center
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Southern Cancer Center — Daphne, Alabama (13.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Infirmary Cancer Care ( Site 0157) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Hernia, Ventral, Hernia, Inguinal
N/A
Interventional 160 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: Tela Bio Inc
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 160 — Mobile, Alabama (4.5 mi)
· Sponsor: Merus B.V.
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0487 — Mobile, Alabama (4.5 mi)
· Sponsor: Bristol-Myers Squibb
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
USA Health Children's and Women's Hospital — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Tricuspid Valve Disease
N/A
Interventional 78 participants sought
Springhill Memorial Hospital — Mobile, Alabama (4.5 mi)
· Sponsor: Corvivo Cardiovascular, Inc.
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
AMR Clinical — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: AstraZeneca
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Alliance for Multispecialty Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: pH-D Feminine Health LLC
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Hepatitis
Phase 3
Interventional 350 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: Bausch Health Americas, Inc.
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Obesity or Overweight, Diabetes Mellitus, Type 2
Phase 3
Interventional 1,500 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: AstraZeneca
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer
Phase 3
Interventional 186 participants sought
The University of South Alabama, Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: Genelux Corporation
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mobile Heart USA Health Cardiology Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
Parkinson Disease, Depressive Symptoms
N/A
Interventional 40 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: University of South Alabama
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Ovarian Cancer
Phase 2
Interventional 160 participants sought
Usa Health Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: Incyte Corporation
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Breast Cancer
Phase 3
Interventional 2,250 participants sought
Southern Cancer Center — Mobile, Alabama (4.5 mi)
· Sponsor: Greenwich LifeSciences, Inc.
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Diagnostic and Medical Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Boehringer Ingelheim
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Phase 2
Interventional 1,200 participants sought
Eastern Shore Research Institute — Fairhope, Alabama (16.6 mi)
· Sponsor: Regeneron Pharmaceuticals
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH